A case of pulmonary edema due to guanfacine intoxication with measurement of serum guanfacine concentrations

J Toxicol Sci. 2023;48(12):641-644. doi: 10.2131/jts.48.641.

Abstract

Guanfacine hydrochloride extended-release (GXR) is used to treat attention deficit hyperactivity disorder. It is a selective α2A-adrenorecepor agonist that was reported to cause QT prolongation and hypotension in the event of overdosing. We report the case of a 17-year-old man who took 226 tablets of GXR 3 mg for attempted suicide. He was found complaining of dyspnea, and emergency medical services were called. When the patient was transferred to our hospital, his Glasgow coma scale was 12 (E4V3M5). He was agitated and hypoxemic. He was intubated for invasive mechanical ventilation under sedation. His chest X-ray and computed tomography scan showed pulmonary edema. Transthoracic echocardiography showed markedly reduced cardiac function. His serum guanfacine concentration peaked on day 3 after admission. His pulmonary edema improved quickly after a decrease in serum guanfacine concentration, but cardiac decompensation persisted for about 1 month. This case reveals that the decline in cardiac function after guanfacine intoxication is prolonged even after its serum concentration has decreased.

Keywords: Guanfacine; Heart failure; Intoxication; Pulmonary edema; Serum concentration.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adrenergic alpha-2 Receptor Agonists / adverse effects
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Delayed-Action Preparations / adverse effects
  • Guanfacine* / blood
  • Guanfacine* / toxicity
  • Humans
  • Male
  • Pulmonary Edema* / chemically induced

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Delayed-Action Preparations
  • Guanfacine